Choleth-24.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 20 11 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: ppublish

Résumé

The Expert Panel for Cosmetic Ingredient Safety reviewed updated information that has become available since their original assessment from 1982, along with updated information regarding product types, and frequency and concentrations of use, and reaffirmed their original conclusion that Choleth-24 is safe for topical applications to humans in the practices of use and concentration as described in this report.

Identifiants

pubmed: 37755708
doi: 10.1177/10915818231204278
doi:

Substances chimiques

polyoxyethylene-24-cholesteryl ether 5UE7I54O43
Polyethylene Glycols 3WJQ0SDW1A
Cosmetics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24S-26S

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review.

Auteurs

Priya Cherian (P)

Cosmetic Ingredient Review Senior Scientific Analyst/Writer.

Wilma F Bergfeld (WF)

Expert Panel for Cosmetic Ingredient Safety Member.

Donald V Belsito (DV)

Expert Panel for Cosmetic Ingredient Safety Former Member.

David E Cohen (DE)

Expert Panel for Cosmetic Ingredient Safety Member.

Curtis D Klaassen (CD)

Expert Panel for Cosmetic Ingredient Safety Member.

Allan E Rettie (AE)

Expert Panel for Cosmetic Ingredient Safety Member.

David Ross (D)

Expert Panel for Cosmetic Ingredient Safety Member.

Thomas J Slaga (TJ)

Expert Panel for Cosmetic Ingredient Safety Member.

Paul W Snyder (PW)

Expert Panel for Cosmetic Ingredient Safety Member.

Susan Tilton (S)

Expert Panel for Cosmetic Ingredient Safety Member.

Monice Fiume (M)

Cosmetic Ingredient Review Senior Director.

Bart Heldreth (B)

Cosmetic Ingredient Review Executive Director.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH